NCT00243295View on ClinicalTrials.gov

Study Evaluating rhMBP-2/CPM in Open Wedge Osteotomies

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

March 31, 2005

Conditions

Osteoarthritis

Interventions

DRUG

rhBMP-2/CPM

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00243295 - Study Evaluating rhMBP-2/CPM in Open Wedge Osteotomies | Biotech Hunter | Biotech Hunter